Driving Improved Outcomes in Resectable Melanoma: Pathways for Optimized Adjuvant Immunotherapy Strategies

Learn more about optimizing adjuvant immunotherapy for patients with resectable stage IIB/C melanoma in this expert-led webcast and accompanying downloadable slideset.

Share

Program Content

No activities added yet

No activities added yet

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC, in partnership with AIM at Melanoma Foundation.

Supporters

Supported by an educational grant from Bristol Myers Squibb.

Bristol Myers Squibb

Partners

AIM at Melanoma Foundation

ProCE Banner